Opaleye Management Inc. - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 215 filers reported holding BRIDGEBIO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.81 and the average weighting 0.5%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q4 2021$5,473,000
-77.2%
328,100
-35.9%
1.16%
-74.1%
Q3 2021$23,974,000
-24.0%
511,500
-1.1%
4.48%
-14.5%
Q2 2021$31,525,000
-12.3%
517,150
-11.4%
5.24%
-0.9%
Q1 2021$35,960,000583,7675.28%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders